Use of human mesenchymal stem cell treatment to prevent anhedonia in a rat model of traumatic brain injury

Abstract

This work has identified a possible role for hMSC in the treatment of TBI-induced depression and other behaviors and suggests a mechanistic role for proliferative cells of the SVZ proliferation in hMSC efficacy.